Cribstone Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-75
| Closed | -$12K | – | 380 |
|
|
2021
Q2 | $12K | Hold |
75
| – | – | 0.01% | 243 |
|
|
2021
Q1 | $9K | Hold |
75
| – | – | 0.01% | 258 |
|
|
2020
Q4 | $11K | Hold |
75
| – | – | 0.01% | 232 |
|
|
2020
Q3 | $6K | Hold |
75
| – | – | ﹤0.01% | 226 |
|
|
2020
Q2 | $6K | Hold |
75
| – | – | 0.01% | 249 |
|
|
2020
Q1 | $3K | Hold |
75
| – | – | ﹤0.01% | 281 |
|
|
2019
Q4 | $5K | Sell |
75
-111
| -60% | -$7.4K | ﹤0.01% | 307 |
|
|
2019
Q3 | $8K | Hold |
186
| – | – | ﹤0.01% | 445 |
|
|
2019
Q2 | $9K | Hold |
186
| – | – | ﹤0.01% | 454 |
|
|
2019
Q1 | $7K | Hold |
186
| – | – | ﹤0.01% | 496 |
|
|
2018
Q4 | $5K | Hold |
186
| – | – | ﹤0.01% | 554 |
|
|
2018
Q3 | $8K | Buy |
186
+75
| +68% | +$3.23K | ﹤0.01% | 548 |
|
|
2018
Q2 | $7K | Hold |
111
| – | – | ﹤0.01% | 570 |
|
|
2018
Q1 | $5K | Buy |
111
+21
| +23% | +$946 | ﹤0.01% | 593 |
|
|
2017
Q4 | $2K | Hold |
90
| – | – | ﹤0.01% | 778 |
|
|
2017
Q3 | $2K | Hold |
90
| – | – | ﹤0.01% | 666 |
|
|
2017
Q2 | $1K | Hold |
90
| – | – | ﹤0.01% | 694 |
|
|
2017
Q1 | $2K | Hold |
90
| – | – | ﹤0.01% | 680 |
|
|
2016
Q4 | $2K | Buy |
+90
| New | +$2K | ﹤0.01% | 628 |
|